Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3664 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sea-squirt drug could targets cancer tumors

The sea-squirt derived drug trabectedin resulted in anti-tumor activity in over half of 51 patients studied with a type of soft tissue sarcoma. Two patients saw their tumors